Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis

Digestive and Liver Disease

Volumn 38, Issue 6, 2006, Pages 389-394

  D'Ovidio, V ^a   Aratari, A ^a   Viscido, A ^a   Marcheggiano, A ^a   Papi, C ^b   Capurso, L ^b   Caprilli, R ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Calprotectine; Granulocyte monocyte apheresis; Inflammatory bowel disease; Mucosal healing; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CALPROTECTIN; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; APHERESIS; ARTICLE; BLOOD CELL COUNT; CATARACT; CELL INFILTRATION; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; FEMALE; FOLLOW UP; GLAUCOMA; GRANULOCYTE; HEALING; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; MONOCYTE; MOON FACE; OUTCOME ASSESSMENT; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GRANULOCYTES; HUMANS; INTESTINAL MUCOSA; LEUKAPHERESIS; MALE; MIDDLE AGED; MONOCYTES; STEROIDS; TREATMENT OUTCOME;

EID: 33748511451     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.12.005     Document Type: Article

References (26)

1. O'Connor J.J. An electron microscope study of inflammatory colonic disease. Dis Col Rectum 15 (1972) 265-277
2. Dvorak A.M., and Dickerson G.R. Crohn's disease: transmission electron microscopic studies I. Barrier function, possible changes related to alterations of cell coat, mucous coat: epithelial cells and Paneth cells. Hum Pathol 11 5 Suppl. (1980) 561-571
3. Saverymuttu S.H., Peters A.M., Lavender J.P., Chadwick V.S., and Hodgson H.J. In vivo assessment of granulocyte migration to diseased bowel in Crohn disease. Gut 26 (1985) 378-383
4. D'Arrigo C., Candal-Couto J.J., Greer M., Veale D.J., and Woof J.M. Human neutrophil Fc receptor mediated adhesion underflow: a hallow fiber model of intravascular arrest. Clin Exp Immunol 100 (1995) 173-179
5. Tibble J., Sigthorsson G., Bridger S., Fagerhol M.K., and Bjarason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119 (2000) 15-22
6. Costa F., Mumolo M.G., Ceccarelli L., Bellini M., Romano M.R., Sterpi C., et al. Calprotectine is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 54 (2005) 364-368
7. Tomomasa T., Kobayashi A., Kaneko H., Mika S., Maisawa S., and Chino Y. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 48 (2003) 750-754
8. Shimoyama T., Sawada K., Hiwatashi N., Sawada T., Matsueda K., and Munakata A. Safety and efficacy of granulocyte adsorptive apheresis in the treatment of acute ulcerative colitis. J Clin Apheresis 16 (2001) 1-9
9. Hanai H., Watanabe F., Takeuchi K., Iida T., Yanada M., Iwaka Y., et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 1 (2003) 28-35
10. Suzuki Y., Naoki Y., Saniabadi A., and Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 49 (2004) 565-571
11. Yamamoto T., Umegae S., Kitagawa T., Yasuda Y., Yanada Y., Takahashi D., et al. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 20 (2004) 783-792
12. Naganuma M., Funakoshi S., Sakuraba A., Takagi H., Inoue N., Ogata H., et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or dependent ulcerative colitis. Inflamm Bowel Dis 10 (2004) 251-257
13. Munkholm P., Langholz E., Davidsen M., and Bider V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35 (1994) 360-362
14. Rachmilewitz D. Coated mesalazine versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 298 (1989) 82-86
15. Floren C.H., Benori C., and Willen R. Histologic and colonscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 22 (1987) 459-462
16. Martin A., Leone L., Fries W., and Naccarato R. Quality of life in inflammatory bowel disease. Italian J Gastroenterol 27 (1995) 450-454
17. Schreiber S., Raedler A., Stenson W.F., and Mac Dermott R.P. The role of mucosal systems in inflammatory bowel disease. Gastroenterol Clin North Am 21 2 (1992) 451-502 [Review]
18. Dinarello C.A., and Wolff S.M. The role of interleukin 1 in disease. N Engl J Med 328 (1993) 106-113
19. Nikolaus S., Bauditz J., Gionchetti P., Witt C., Lochs H., and Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 42 (1998) 470-476
20. Nusrat A., Turner J.R., and Madara J.L. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines and immune cells. Am J Physiol 279 (2000) G851-G857
21. Mitsuyama K., Suzuki A., Matsumoto S., Tomiyasu N., Takakai K., Takedatsu H., et al. Diminished cytokine signalling against bacterial components in mononuclear leukocytes from ulcerative colitis patients after leukocytapheresis. Clin Exp Immunol 141 (2005) 130-140
22. Roseth A.G., Aaland E., Jahnsen J., and Raknerud N. Assessment of disease activity in ulcerative colitis by fecal calprotectine, a novel granulocyte marker protein. Digestion 58 (1997) 176-180
23. Hanai H., Watanab F., Yamada M., Sato Y., Takeuchi K., Iida T., et al. Correlation of serum soluble TNF-α receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 99 (2004) 1532-1538
24. Hogg N., and Berlin C. Structure and function of adhesion receptors in leukocyte trafficking. Immunol Today 16 (1995) 327-330
25. Dransfield I., Stocks S.G., and Haslen C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 85 (1995) 3246-3253
26. Vandenabeele P., Declercq W., Beyaert R., and Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5 (1995) 392-399